NCT03700112View on ClinicalTrials.gov

Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 4, 2018

Primary Completion Date

February 24, 2019

Study Completion Date

April 9, 2019

Conditions
Nicotine DependenceNicotine Dependence, CigarettesTobacco UseTobacco Smoking
Interventions
OTHER

JUUL Virginia Tobacco flavored 5.0% ENDS

Virginia Tobacco Flavored 5.0% ENDS product is administered using a controlled method and adlibitum

OTHER

PMI iQOS Heat sticks

PMI IQOS Heat sticks is administered using a controlled method and ad-libitum

OTHER

Reynolds VUSE Solo ENDS - Original

Reynolds VUSE solo ENDS - Original is administered using a controlled method and ad-libitum

OTHER

Imperial MyBlu ENDS - Original

Imperial MyBlu ENDS- original is administered using a controlled method and ad-libitum

OTHER

Altria MarkTen ENDS - Bold Classic

Altria MarkTen ENDS - Bold Classic is administered using a controlled method and ad-libitum

OTHER

MLV PHIX ENDS - Original Tobacco

MLV PHIX ENDS - Original Tobacco is administered using a controlled method and ad-libitum

OTHER

NJOY Daily EXTRA ENDS - Rich Tobacco

NJOY Daily EXTRA ENDS - Rich Tobacco is administered using a controlled method and ad-libitum

OTHER

Altria Marlboro combustible cigarette - Red

Altria Marlboro combustible cigarette - Red is administered using a controlled method and ad-libitum

Trial Locations (1)

8011

Christchurch Clinical Studies Trust Ltd, Christchurch

All Listed Sponsors
lead

Juul Labs, Inc.

INDUSTRY

NCT03700112 - Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods. | Biotech Hunter | Biotech Hunter